Computational BioMedicine Laboratory

REACTION

Category: european

Project Title: Remote Accessibility to Diabetes Management and Therapy in Operational Healthcare Networks

Funding Organization: EC

Programme: FP7-IP-No 248590

Coordinator: Atos Origin (ATOS), Spain

Partners: CNet Svenska AB (CNET) Sweden, Delta (DELTA) Denmark, Institut fur Mikrotechnik Mainz GmbH (IMM) Germany, Foundation for Research and Technology Hellas (FORTH-ICS) Greece, Fraunhofer-Institut fur Sichere Informationstechnologie (FHG-SIT) Germany, FORTHNET S.A. (FORTHNET) Greece, In-Jet ApS (IN-JET) Denmark, Applied Logic Laboratory (ALL) Hungary, Medical University of Graz (MUG) Austria, Institute of Medical Technologies and Health Management (MSG) Austria, Chorleywood Health Centre (CHC) United Kingdom, Brunel University (UBRUN) United Kingdom, Vrije Universiteit Brussel (VUB) Belgium, Bayer Technology Services GmbH (BTS) Germany, Solianis Holding AG (SOLIANIS) Switzerland

Duration: 01/03/2010-28/02/2014

Expiration Date: 2013

Total Budget: 14.412.539 €

FORTH ICS budget: 1.030.450 €

Web Site: http://www.reactionproject.eu/

Project Objective: The REACTION project will develop an integrated approach to improve long term management of diabetes, continuous blood glucose monitoring, clinical monitoring and intervention strategies, monitoring and predicting related disease indicators, complemented by education on life style factors such as obesity and exercise and, ultimately, automated closed-loop delivery of insulin. The REACTION platform will feature an interoperable peer-to-peer communication platform based on service oriented architecture (SOA) where all functionalities, including devices, are represented as services and applications consisting of a series of services orchestrated to perform a desired workflow. The REACTION platform also features a model driven application development environment based on extensive use of dynamic ontologies and advanced data management capabilities with algorithms for clinical assessment and rule-based data processing. The intelligent, interoperable platform developed by REACTION will provide integrated, professional management and therapy services to diabetic patients in different healthcare regimes across Europe, including 1) professional decision support for in-hospital environments, 2) safety monitoring for drug dosage and compliance, 3) long term management of patients in out-of-hospital environments, 4) care of acute diabetic conditions and 5) support for self management and life-style changes. A range of REACTION services will be developed targeted to insulin-dependent type 1 diabetic patients. The services aim to improve continuous blood glucose monitoring and insulin therapy, by both basal dose adjustment and contextualized glycaemic control based on patient activity, nutrition, administered drugs, etc. Decision support will assist healthcare professionals, patients and informal carers to better manage diabetes therapy and make correct choices about e.g. good blood glucose control, nutrition and exercise.

Conditions of Use | Privacy Policy